“Study of Levofloxacin and Cefoperazone-Sulbactam Utilization Cost on Patients with Mild and Moderate Corona Virus Disease- 2019: Studi Biaya Penggunaan Antibiotik Levofloxacin dan Cefoperazone-Sulbactam pada Pasien Corona Virus Disease-2019 Derajat Ringan sampai Sedang”, Pharmasci, vol. 9, no. 1, pp. 59–63, Jun. 2024, doi: 10.53342/pharmasci.v9i1.316.